NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









iosBio

iosBio

Private
Haywards HeathHealthcare & Life Scienceshttps://iosbio.com/

Last Round

Series A

May 1, 2025

Total Funding Raised

$390,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

iosBio is a biotechnology company that develops thermostable, orally delivered vaccines for major infectious diseases using its proprietary OraPro™ and Enhanced Surface Display (ESD™) technology platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

oral vaccinethermostable vaccineneedle-free deliveryself-administered vaccinecold-chain freeviral vectormucosal immunityantigen designbiotech licensingpill vaccinevaccine platformcomputational biologyin-silico design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iosBio Comparables

Compare iosBio with similar companies based on industry and business-model similarity.

iosBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

iosBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2025
GrantFeb 23, 2022
VC RoundMay 12, 2020
VC RoundMar 18, 2009

Key People

Founding team and executive leadership

Craig Laferrière

Board Member, Chief Development Officer (CDO)

Executive Team

iosBio Investors

Notable investors and investment history

iosBio investors
InvestorRounds
Shackleton VenturesVC Round
DHSCGrant
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors increased 279% MoM.

  • Jan 22, 2026

    Monthly visitors increased 1108% MoM.

iosBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iosBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iosBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersHaywards Heath
Employee Range12
Year Founded2002
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.